IONLACE Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 3

IONLACE General Information

Description

Developer of an AI-based synthetic biotechnology platform intended to design and produce novel proteins. The company's platform accelerates the process from sequence to expression and validation by orders of magnitude compared to conventional methods, generating high-resolution data at each step, enabling businesses and healthcare professionals to build foundational technologies that propel human health while fine-tuning their protein production process

Contact Information

Website
www.ionlace.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Nanna Svartz väg 4
  • Solna
  • 171 65 Stockholm
  • Sweden
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • Nanna Svartz väg 4
  • Solna
  • 171 65 Stockholm
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IONLACE Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 30-Apr-2024 Completed Generating Revenue
1. Early Stage VC 31-Jul-2023 Completed Generating Revenue
To view IONLACE’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

IONLACE Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IONLACE Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
201 Ventures Venture Capital Minority
ACME Capital Venture Capital Minority
Heartcore Capital Venture Capital Minority
To view IONLACE’s complete investors history, request access »

IONLACE FAQs

  • When was IONLACE founded?

    IONLACE was founded in 2023.

  • Where is IONLACE headquartered?

    IONLACE is headquartered in Stockholm, Sweden.

  • What is the size of IONLACE?

    IONLACE has 12 total employees.

  • What industry is IONLACE in?

    IONLACE’s primary industry is Discovery Tools (Healthcare).

  • Is IONLACE a private or public company?

    IONLACE is a Private company.

  • What is IONLACE’s current revenue?

    The current revenue for IONLACE is .

  • Who are IONLACE’s investors?

    201 Ventures, ACME Capital, and Heartcore Capital have invested in IONLACE.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process